Home Chemicals & Materials Industrial Gases Inhaled Nitric Oxide Market

Inhaled Nitric Oxide Market Size, Share & Trends Analysis Report By Application (Neonatal respiratory treatment, Chronic obstructive pulmonary disease (COPD), Acute respiratory distress syndrome (ARDS)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Anantika Sharma | Format: | Report Code: SR1935DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Inhaled Nitric Oxide Market Size Analysis
    1. Introduction
    2. Inhaled Nitric Oxide Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Neonatal respiratory treatment
      2. Chronic obstructive pulmonary disease (COPD)
      3. Acute respiratory distress syndrome (ARDS)
  7. North America Inhaled Nitric Oxide Market Size Analysis
    1. Introduction
    2. Inhaled Nitric Oxide Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Neonatal respiratory treatment
      2. Chronic obstructive pulmonary disease (COPD)
      3. Acute respiratory distress syndrome (ARDS)
    3. U.S.
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    4. Canada
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
  8. Europe Inhaled Nitric Oxide Market Size Analysis
    1. Introduction
    2. Inhaled Nitric Oxide Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Neonatal respiratory treatment
      2. Chronic obstructive pulmonary disease (COPD)
      3. Acute respiratory distress syndrome (ARDS)
    3. U.K.
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    4. Germany
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    5. France
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    6. Spain
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    7. Italy
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    8. Russia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    9. Nordic
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    10. Benelux
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    11. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
  9. APAC Inhaled Nitric Oxide Market Size Analysis
    1. Introduction
    2. Inhaled Nitric Oxide Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Neonatal respiratory treatment
      2. Chronic obstructive pulmonary disease (COPD)
      3. Acute respiratory distress syndrome (ARDS)
    3. China
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    4. Korea
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    5. Japan
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    6. India
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    7. Australia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    8. Taiwan
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    9. South East Asia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    10. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
  10. Middle East and Africa Inhaled Nitric Oxide Market Size Analysis
    1. Introduction
    2. Inhaled Nitric Oxide Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Neonatal respiratory treatment
      2. Chronic obstructive pulmonary disease (COPD)
      3. Acute respiratory distress syndrome (ARDS)
    3. UAE
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    4. Turkey
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    5. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    6. South Africa
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    7. Egypt
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    8. Nigeria
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    9. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
  11. LATAM Inhaled Nitric Oxide Market Size Analysis
    1. Introduction
    2. Inhaled Nitric Oxide Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Neonatal respiratory treatment
      2. Chronic obstructive pulmonary disease (COPD)
      3. Acute respiratory distress syndrome (ARDS)
    3. Brazil
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    4. Mexico
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    5. Argentina
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    6. Chile
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    7. Colombia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
    8. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Neonatal respiratory treatment
        2. Chronic obstructive pulmonary disease (COPD)
        3. Acute respiratory distress syndrome (ARDS)
  12. Competitive Landscape
    1. Inhaled Nitric Oxide Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Air Liquide S.A.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bellerophon Therapeutics Inc.
    3. BOC Healthcare
    4. Beyond Air Inc.
    5. Halma Plc
    6. Linde Plc (Praxair Inc.)
    7. Mallinckrodt Plc
    8. Novoteris LLC
    9. Vero Biotech Llc
    10. Nu-Med Plus
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.